secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monte Rosa Therapeutics, Inc. (GLUE)
CIK:        0001826457
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0000950170-24-072407
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Monte Rosa Therapeutics 2024 annual meeting results: directors elected, auditor ratified
--------------------------------------------------------------------------------

- Markus Warmuth, M.D. elected with 39,473,886 votes for, 84,415 withheld; Ali Behbahani, M.D. with 23,794,947 for, 15,763,354 withheld.
- Ratification of Deloitte & Touche LLP as independent auditor for FY 2024 approved: 40,409,003 for, 59,893 against, 3 abstentions.
- No other matters were submitted to a vote at the June 12, 2024 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826457/000095017024072407/0000950170-24-072407-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826457/000095017024072407/glue-20240612.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-072407

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer